Linda Mileshkin
Impact in
- Obstetrics and Gynecology top 0.05%
- Endometrial and Cervical Cancer Treatments
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
-
- Endometrial and Cervical Cancer Treatments 70
- Oncology 130
- Cancer Diagnosis and Treatment 32
- PARP inhibition in cancer therapy 22
- Cancer survivorship and care 19
- Co-authors
- Henry Charles Kitchener (9 shared papers)Henry Miles Prince (20 shared papers)Akila N. Viswanathan (3 shared papers)David K. Gaffney (5 shared papers)William Small Jr. (4 shared papers)Linus T Chuang (3 shared papers)Anuja Jhingran (3 shared papers)Monica A. Bacon (3 shared papers)
- Journals
- International Journal of Gynecological Cancer (29 papers)Annals of Oncology (25 papers)Gynecologic Oncology (18 papers)Nature Communications (17 papers)The Lancet Oncology (12 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Linda Mileshkin
301 papers receiving 22.9k citations
Linda Mileshkin's Hit Papers
Peers
Comparison fields: 5 of 178
- Obstetrics and Gynecology 3.4k
- Cancer Research 5.8k
- Reproductive Medicine 2.9k
- Oncology 7.3k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Linda Mileshkin
This map shows the geographic impact of Linda Mileshkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Mileshkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Mileshkin more than expected).
Fields of papers citing papers by Linda Mileshkin
This network shows the impact of papers produced by Linda Mileshkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Mileshkin. The network helps show where Linda Mileshkin may publish in the future.
Co-authors
The 25 scholars most cited alongside Linda Mileshkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 316 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The repertoire of mutational signatures in human cancer Hit paper breakdown → | 2020 | 2339 |
| 2 | Pan-cancer analysis of whole genomes Hit paper breakdown → | 2020 | 2109 |
| 3 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1562 |
| 4 | Whole–genome characterization of chemoresistant ovarian cancer Hit paper breakdown → | 2015 | 1233 |
| 5 | Cervical cancer: A global health crisis Hit paper breakdown → | 2017 | 902 |
| 6 | The evolutionary history of 2,658 cancers Hit paper breakdown → | 2020 | 705 |
| 7 | Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy Hit paper breakdown → | 2020 | 588 |
| 8 | Patterns of somatic structural variation in human cancer genomes Hit paper breakdown → | 2020 | 550 |
| 9 | Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing Hit paper breakdown → | 2020 | 476 |
| 10 | Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial Hit paper breakdown → | 2018 | 463 |
| 11 | Analyses of non-coding somatic drivers in 2,658 cancer whole genomes Hit paper breakdown → | 2020 | 419 |
| 12 | Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative Hit paper breakdown → | 2015 | 392 |
| 13 | 2016 | 377 | |
| 14 | Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study Hit paper breakdown → | 2022 | 356 |
| 15 | Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial Hit paper breakdown → | 2019 | 337 |
| 16 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 319 |
| 17 | 2020 | 317 | |
| 18 | Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition Hit paper breakdown → | 2020 | 309 |
| 19 | 2020 | 301 | |
| 20 | 2020 | 293 |
About Linda Mileshkin
Linda Mileshkin is a scholar working on Obstetrics and Gynecology, Oncology, Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 316 papers that have together received 23.2k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (70 papers), Cancer Genomics and Diagnostics (32 papers), Cancer Diagnosis and Treatment (32 papers), Ovarian cancer diagnosis and treatment (28 papers), PARP inhibition in cancer therapy (22 papers), Cancer survivorship and care (19 papers), Genetic factors in colorectal cancer (19 papers) and Multiple Myeloma Research and Treatments (15 papers). The work is most often cited by research in Obstetrics and Gynecology (3.4k citations), Cancer Research (5.8k citations), Reproductive Medicine (2.9k citations), Oncology (7.3k citations) and Pathology and Forensic Medicine (2.2k citations). Linda Mileshkin has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Henry Charles Kitchener, Henry Miles Prince, Akila N. Viswanathan, David K. Gaffney, William Small Jr., Linus T Chuang, Anuja Jhingran, Monica A. Bacon, Brandon J. Fisher and Amishi Bajaj. Their work appears in journals such as International Journal of Gynecological Cancer, Annals of Oncology, Gynecologic Oncology, Nature Communications and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.